Renal Protectant Activity of Cochlearia armoracia in 5/6-Nephrectomized Rat Model

 

Shanish Antony A.*, Jayasankar K., Partha Deb Roy, Pankaj N., Dhamodaran P., Duraiswamy B. and Elango K.

Department of Pharmacology, JSS College of Pharmacy, Ooty-643001, Tamilnadu, India

ABSTRACT:

We investigated the effect of aqueous and ethanolic extract of Cochlearia armoracia at a dose of 200 and 400mg/kg in 5/6 nephrectomized rats for its nephroprotective activity. Blood samples were collected for the measurement of serum creatinine, urea, blood urea nitrogen, uric acid. Urine samples were collected for the measurement of urine volume, sodium and potassium excretion levels. In nepherctomized rat the blood parameters were significantly increased and urine parameters were significantly altered to disease condition. Both the extracts at a dose level of 400mg/kg showed significant (p<0.01) decrease in serum creatinine, urea, blood urea nitrogen, uric acid and increases urinary volume and sodium and potassium excretions. The present study revealed that the oral administration of aqueous and ethanolic extracts at 400mg/kg dose exhibit a significant nephroprotective activity in 5/6 nephrectomized rat model.

 

KEYWORDS: Cochlearia armoracia; Nephrectomized and Nephroprotective

 

1. INTRODUCTION

The roots of Cochlearia armoracia Linn belongs to family Cruciferae, is widely growing plant mainly in Western Ghats of Nilgiri hills and was universally used as a medicine during middle age and as a condiment in Denmark and Germany (Grieve, 1995; Bown, 1996).This root was included in Materia Medica of London Pharmacopoeia of eighteen centuries. This plant is available in few parts of Nilgiris and widely used as a traditional medicine. The main phytoconstituents that are present are mainly glycoside and coumarins (Hansen, 1974). The roots of this plant is claimed to be used as a diuretic (Chopra et al., 1992) and also used to treat kidney disorders like kidney stones and edema (Goldberg et al., 1998). But scientifically the diuretic activity has not reported and also the effect of Cochlearia armoracia in chronic renal failure model has not yet established. In the present communication we report the renal protectant activity of the root of Cochlearia armoracia in rat model of chronic renal failure.

 

 

2. METERIALS AND METHODS:

2.1. Collection of plant material:

The roots of Cochlearia armoracia were collected during June 2009, from the local areas of Nilgiris. The roots were identified and authenticated by Botanist, Government Botanical Garden, Udagamandalam. The voucher specimen was deposited in the herbarium of the department of Pharmacognosy, JSS College of Pharmacy, Ooty.

 

 


Table 1: Effect of the aqueous and the ethanolic extracts on urinary and metabolites excretion in nephrectomized rat after 15 days of treatment.

Groups

Treatment

Urinary excretion ml/day

Sodium ion concentration (meq/day)

Potassium ion concentration (meq/day)

1

Control

7.67 ± 1.08

24.38 ± 2.12

30.52±3.01

2

Aqueous extract 200mg/kg

10.45 ± 1.98**

34.30 ± 0.81**

41.56±2.14**

3

Aqueous extract 400mg/kg

14.95 ± 2.57**

38.72 ± 1.56**

48.83±1.65**

4

Ethanolic extract 200mg/kg

9.81 ± 1.28*

32.81 ± 1.24**

40.09±1.81**

5

Ethanolic extract 400mg/kg

12.91 ± 2.02**

36.09 ± 2.57**

46.92±1.63**

Value represents mean ± SEM of six animals in each group, Significant difference from the control, *P<0.05, **P<0.01.

 

Table 2: Effect of the aqueous and the ethanolic extracts on creatinine, urea, uric acid and blood urea nitrogen in nephrectomized rats after 15 days of treatment.

Groups

Treatment

Creatinine (mg/dl)

Urea (mg/dl)

Blood urea  nitrogen (mg/dl)

Uric acid (mg/dl)

1

Control

16.18 ± 0.47

170.8 ± 21.94

79.79 ± 10.24

11.23 ± 2.83

2

Aqueous extract 200mg/kg

2.88 ± 0.19**

26.08 ± 2.41**

12.17 ±1.12**

4.57 ± 1.52**

3

Aqueous extract 400mg/kg

1.03 ± 1.13**

25.56 ± 1.13**

11.93 ±0.52**

2.59 ± 3.81**

4

Ethanolic extract 200mg/kg

3.93 ±1.13**

45.71 ± 2.48**

21.34 ±1.65**

3.56 ± 2.96**

5

Ethanolic extract 400mg/kg

2.03 ± 0.45**

33.21 ± 2.32**

15.50 ±2.14**

1.85 ± 1.08**

Value represents mean ± SEM of six animals in each group, Significant difference from the control, *P<0.05, **P<0.01.

 

 


2.2. Preparation of the extracts:

The collected roots were shade dried and powdered. The dried powder of the root of Cochlearia armoracia was subjected for cold maceration with water and 70% ethanol for 5 days with occasional shaking and heating. At the end of fifth day both were filtered through Buchner funnel. The filtrates were concentrated by vacuum distillation. The concentrates were kept in petriplates and dried in freeze drier until free from moisture. It was than weighed and kept in vacuum desiccators to free from moisture and was used for further studies. The yield for aqueous and ethanolic extracts was 20.8% and 18.6% w/w respectively.

 

2.3. Animals:

Healthy adult wistar rats, weighing 180-250 g, were obtained from Animal house, JSS College of Pharmacy, Ooty, India and maintained under standard laboratory conditions. The experimental protocol was approved from Institutional Animal Ethical Committee (IAEC). The animal experiments were carried out as per CPCSEA guidelines and after IAEC approval.

 

2.4. Nephroprotective activity:

Renal damage was induced in rats by 5/6 nephrectomy method according to the earlier reported procedure (Podjarny et al., 2004; Braunlich et al., 1997). All animals were allowed free acess to tap water and pellet diet and maintained at room temparature in plastic cages.

 

2.5. Experimental design:

The rats were divided into five groups, consisting six animals in each group.

Group 1 Control group, treated with saline (2 ml/kg, p.o) daily for 15 days

Group 2 Treated with aqueous extract 200 mg/kg b.w. daily for 15 days

Group 3 Treated with aqueous extract 400 mg/kg b.w. daily for 15 days

Group 4 Treated with ethanol extract 200 mg/kg b.w. daily for 15 days

Group 5 Treated with ethanol extract 400 mg/kg b.w. daily for 15 days

 

At the end of the treatment urine was collected by metabolic cages and blood samples were collected through tail vein. The urine volume and the excretion of metabolites, sodium and potassium ions were estimated according to the earlier procedure (Afzal et al., 2004; Ganapathy et al., 2002). Blood samples were collected in sterile centrifuge tubes allowed to clot. Serum was separated and estimated for creatinine, urea, blood urea nitrogen and uric acid (Englert and Harish, 1992).

 

2.6. Statistical analysis:

The values are represented as mean ± SEM. The results were analyzed statistically by one-way analysis of variance (ANOVA), followed by Dunnett’s post hoc test. “p” value of <0.01 was taken considered to be significance.

 

3. RESULT AND DISCUSSION:

The effect of the root of Cochlearia armoracia on urinary volume and excretion of sodium and potassium ions was given in Table 1. Treatment with aqueous and ethanolic extracts of Cochlearia armoracia showed significant increase in urinary volume and excretion of sodium and potassium ions. Animal received only saline after nephrectomy (Control) had shown much decrease in urinary volume and excretion of sodium and potassium ions. The effect of the root of Cochlearia armoracia on Serum creatinine, urea, blood urea nitrogen and uric acid was given in Table 2. Treatment with aqueous and ethanolic extracts of Cochlearia armoracia showed significant decrease in the levels of Serum Creatinine, Urea, Blood urea nitrogen and Uric acid. Animal receives only saline after nephrectomy (Control) had showed much increase in creatinine, urea, blood urea nitrogen and uric acid concentration in serum. Aqueous and ethanolic extracts reverse the effect of the renal failure caused by nephrectomy. Aqueous and ethanolic extracts protected rats by lowering creatinine, urea, blood urea nitrogen and uric acid concentration in serum after 15 days of the treatment. Aqueous and ethanolic extract (400mg/kg) shows marked decrease in creatinine, urea, blood urea nitrogen and uric acid levels as well as increase the urinary volume and excretion of sodium and potassium ions.

 

4. CONCLUSION:

On the basis of the result obtained, it can be concluded that the aqueous and ethanolic extract of the roots of Cochlearia armoracia seems to possess renal protecting activity in the rats. The results seem to support the traditional use of this plant in renal protection.

 

5. ACKNOWLEDGEMENT:

The authors are grateful to the management, JSS College of Pharmacy, for providing the necessary infrastructure to carry out this research work in a successful manner.

 
6. REFERENCES:

1.       Grieve M. A Modern Herbal. Dover Publication Inc, New York. 1995.

2.       Bown D. Encyclopedia of herbs and their uses. DK Publishing Inc, New York. 1996.

3.       Hansen L. Content of glucosinolates in Horseradish(Armoracia Rusticana). Tidsskr Planteavl. 1974; 73: 408-410.

4.       Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. Council of Scientific and Industrial Research, New Delhi. 1992.

5.       Goldberg A, Busse WR, Bluementhal M. A therapeutic guide to herbals: The commission E Monographs. Boston, 1998.

6.       Podjarny E, Hasdan G, Bernheim J, Rashid G, Green J, Korzets Z et al. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats. Nephrol Dial Transplant. 2004; 19: 2223-27.

7.       Braunlich H, Marx F, Fleck C, Stein G. Kidney function in rats after 5/6 nephrectomy (5/6 NX): effort of treatment with vitamin E. Exp Toxicol Pathol. 1997; 12: 135-139.

8.       Afzal M, Iqbal A, Inamuddin M.  Diuretic and nephroprotective effect of Jawarish Zarooni Sada- a polyherbal unani formulation.  J Ethnopharmacol. 2004; 91: 219-223.

9.       Ganapathy S, Dash GK, Subburaju T, Suresh P. Diuretic, laxative and toxicity studies of Cocculus hirsutus aerial parts. Fitoterapia 2002; 73: 28-31.

10.     Englert J, Harmish Feger G. Diuretic action of aqueous Orthosiphon extract in rats. Planta Medica. 1992; 58; 237-238.

 

 

Received on 04.02.2010

Accepted on 17.02.2010     

© A&V Publication all right reserved

Research J. Pharmacology and Pharmacodynamics. 2(4): July-August 2010, 300-302